Harvard Bioscience (HBIO) Accounts Payables (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Accounts Payables of $5.3 million for Q1 2026, up 9.96% year-over-year from $4.8 million in Q1 2025, and up 44.77% quarter-over-quarter from $3.7 million in Q4 2025.
Harvard Bioscience (HBIO) Accounts Payables (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Accounts Payables for 17 consecutive years, with $5.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables rose 9.96% year-over-year to $5.3 million; the TTM figure through Mar 2026 stood at $5.3 million (up 9.96% YoY), while the FY2025 annual figure was $3.7 million, down 23.71% from the prior year.
- Accounts Payables grew to $5.3 million in Q1 2026 per HBIO's latest filing, from $3.7 million in the prior quarter.
- Across five years, Accounts Payables topped out at $6.8 million in Q2 2022 and bottomed at $3.7 million in Q4 2025.
- Historically, Accounts Payables has averaged $5.5 million across 5 years, with a median of $5.6 million in 2023.
- Annual changes were most pronounced in 2022 — Accounts Payables jumped 31.28% — and 2023, when it sank 30.75%.
- Harvard Bioscience's Accounts Payables stood at $6.4 million in 2022, then slipped by 13.85% to $5.6 million in 2023, then decreased by 13.81% to $4.8 million in 2024, then declined by 23.71% to $3.7 million in 2025, then soared by 44.77% to $5.3 million in 2026.
- Business Quant data shows HBIO's Accounts Payables at $5.3 million in Q1 2026, $3.7 million in Q4 2025, and $5.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 277.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 6.11 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 968.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 308.92 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 1.04 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 252.70 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 701.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 233.30 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 1.03 Bn |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | 6.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.22 Mn |
| Mar 31, 2026 | 5.29 Mn |
| Dec 31, 2025 | 3.65 Mn |
| Sep 30, 2025 | 5.18 Mn |
| Jun 30, 2025 | 4.72 Mn |
| Mar 31, 2025 | 4.81 Mn |
| Dec 31, 2024 | 4.79 Mn |
| Sep 30, 2024 | 5.28 Mn |
| Jun 30, 2024 | 5.71 Mn |
| Mar 31, 2024 | 6.04 Mn |
| Dec 31, 2023 | 5.55 Mn |
| Sep 30, 2023 | 6.27 Mn |
| Jun 30, 2023 | 4.72 Mn |
| Mar 31, 2023 | 5.98 Mn |
| Dec 31, 2022 | 6.45 Mn |
| Sep 30, 2022 | 5.88 Mn |
| Jun 30, 2022 | 6.81 Mn |
| Mar 31, 2022 | 6.22 Mn |
| Dec 31, 2021 | 4.91 Mn |
| Sep 30, 2021 | 5.62 Mn |